JP2002511864A5 - - Google Patents

Download PDF

Info

Publication number: JP2002511864A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1999504389A

Other languages

English (en)

Other versions

JP2002511864A (ja

Filing date

1998-04-08

Publication date

2005-12-02

1997-06-23 Priority claimed from US08/880,945 external-priority patent/US5929055A/en

1998-04-08 Application filed filed Critical

2002-04-16 Publication of JP2002511864A publication Critical patent/JP2002511864A/ja

2005-12-02 Publication of JP2002511864A5 publication Critical patent/JP2002511864A5/ja

Status Ceased legal-status Critical Current

Description

JP50438999A 1997-06-23 1998-04-08 糖尿病管理のための治療方法 Ceased JP2002511864A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/880,945		1997-06-23
US08/880,945 US5929055A (en)	1997-06-23	1997-06-23	Therapeutic method for management of diabetes mellitus
PCT/US1998/006927 WO1998058658A1 (en)	1997-06-23	1998-04-08	Therapeutic method for management of diabetes mellitus

Publications (2)

Publication Number	Publication Date
JP2002511864A JP2002511864A (ja)	2002-04-16
JP2002511864A5 true JP2002511864A5 (ja)	2005-12-02

Family

ID=25377455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP50438999A Ceased JP2002511864A (ja)	1997-06-23	1998-04-08	糖尿病管理のための治療方法

Country Status (9)

Country	Link
US (1)	US5929055A (ja)
EP (1)	EP1017414A4 (ja)
JP (1)	JP2002511864A (ja)
KR (1)	KR20010020497A (ja)
AU (1)	AU744846B2 (ja)
CA (1)	CA2294169A1 (ja)
IL (1)	IL133643A0 (ja)
MX (1)	MXPA99011821A (ja)
WO (1)	WO1998058658A1 (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP9902721A2 (hu)	1997-11-25	1999-12-28	The Procter & Gamble Co.	Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
JP2002525299A (ja) *	1998-09-28	2002-08-13	ザリサーチファウンデーションオブステイトユニヴァーシティオブニューヨーク	新規白内障形成抑制剤
US6914057B1 (en)	1998-09-28	2005-07-05	The Research Foundation Of State University Of New York	Inhibitor of cataract formation
EP1385549A2 (en) *	2001-03-12	2004-02-04	Novartis AG	Combination of nateglinide or repaglinide with at least one further antidiabetic compound
KR100982753B1 (ko) *	2001-04-05	2010-09-16	콜라제넥스 파마슈티칼스, 인크	테트라사이클린 화합물 및 테트라사이클린 유도체의 전달조절
FR2826278B1 (fr) *	2001-06-20	2005-03-25	Lipha	Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
DK1397124T3 (da) *	2001-06-20	2007-04-02	Merck Sante Sas	Anvendelse af diabetesmidler til fremstilling af et lægemiddel med helende virkning
EP1408987B1 (en)	2001-07-13	2013-04-10	Paratek Pharmaceuticals, Inc.	Tetracycline compounds having target therapeutic activities
US20050107441A1 (en) *	2001-12-21	2005-05-19	Kliewer Steven A.	Compositions and methods for altering glucose production
EP2311798A1 (en)	2002-01-08	2011-04-20	Paratek Pharmaceuticals, Inc.	4-dedimethylamino tetracycline compounds
EA200802365A1 (ru)	2002-03-08	2009-08-28	Паратек Фармасьютикалс, Инк.	Аминометилзамещенные тетрациклиновые соединения
IL164180A0 (en)	2002-03-21	2005-12-18	Paratek Pharm Innc	Substituted tetracycline compounds
WO2004006850A2 (en)	2002-07-12	2004-01-22	Paratek Pharmaceuticals, Inc	3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS
US7749532B2 (en)	2003-04-07	2010-07-06	Supernus Pharmaceuticals, Inc.	Once daily formulations of tetracyclines
WO2005009943A2 (en)	2003-07-09	2005-02-03	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
JP4738333B2 (ja)	2003-07-09	2011-08-03	パラテックファーマシューティカルズインコーポレイテッド	９−アミノメチルテトラサイクリン化合物のプロドラッグ
CA2553510C (en)	2004-01-15	2012-09-25	Paratek Pharmaceuticals, Inc.	Aromatic a-ring derivatives of tetracycline compounds
EP2949644A3 (en)	2004-10-25	2016-04-20	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
CA2585418A1 (en)	2004-10-25	2006-05-04	Paratek Pharmaceuticals, Inc.	4-aminotetracyclines and methods of use thereof
CA2616224A1 (en) *	2005-07-21	2007-02-01	Paratek Pharmaceuticals, Inc.	10-substituted tetracyclines and methods of use thereof
US20070098763A1 (en) *	2005-10-11	2007-05-03	Sinnott Robert A	Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
PT2120963T (pt) *	2006-12-21	2018-12-17	Paratek Pharm Innc	Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
US8318706B2 (en)	2006-12-21	2012-11-27	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds
CA2688662A1 (en)	2007-04-27	2008-11-06	Paratek Pharmaceuticals, Inc.	Methods for synthesizing and purifying aminoalkyl tetracycline compounds
ATE555079T1 (de) *	2007-07-06	2012-05-15	Paratek Pharm Innc	Verfahren zur synthese von 9-substituiertem minocyclin
TW202216656A (zh)	2008-05-23	2022-05-01	美商ＰｒｔｋＳｐｖ２公司	四環素化合物之甲苯磺酸鹽及同素異形體
ES2558512T3 (es)	2008-08-08	2016-02-04	Tetraphase Pharmaceuticals, Inc.	Compuestos de tetraciclina sustituida con C7-fluoro
CN102459153A (zh)	2009-05-08	2012-05-16	四相制药公司	四环素类化合物
CN105622496B (zh)	2009-08-28	2019-03-05	四相制药公司	四环素类化合物
PL2552890T3 (pl)	2010-03-31	2017-07-31	Tetraphase Pharmaceuticals, Inc.	Policykliczne związki tetracyklinowe
PT2890673T (pt)	2012-08-31	2019-02-19	Tetraphase Pharmaceuticals Inc	Compostos de tetraciclina
US9171343B1 (en)	2012-09-11	2015-10-27	Aseko, Inc.	Means and method for improved glycemic control for diabetic patients
US9897565B1 (en)	2012-09-11	2018-02-20	Aseko, Inc.	System and method for optimizing insulin dosages for diabetic subjects
US9486580B2 (en)	2014-01-31	2016-11-08	Aseko, Inc.	Insulin management
US9233204B2 (en)	2014-01-31	2016-01-12	Aseko, Inc.	Insulin management
US11081226B2 (en)	2014-10-27	2021-08-03	Aseko, Inc.	Method and controller for administering recommended insulin dosages to a patient
WO2016069475A1 (en)	2014-10-27	2016-05-06	Aseko, Inc.	Subcutaneous outpatient management
US9886556B2 (en)	2015-08-20	2018-02-06	Aseko, Inc.	Diabetes management therapy advisor
US10961190B2 (en)	2016-10-19	2021-03-30	Tetraphase Pharmaceuticals, Inc.	Crystalline forms of eravacycline
WO2020097450A1 (en)	2018-11-09	2020-05-14	Tetraphase Pharmaceuticals, Inc.	Polymorphic forms of a compound and uses thereof
EA202193111A1 (ru)	2019-05-14	2022-02-10	Тайм, Инк.	Композиции и способы для лечения рака
CA3179419A1 (en) *	2020-04-08	2021-10-14	Hoffman Technologies Llc	Methods of treating conditions characterized by insulin deficiency in animals
US10905698B1 (en)	2020-05-14	2021-02-02	Tyme, Inc.	Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4292585A (en) *	1984-04-30	1985-11-28	Trustees Of Columbia University In The City Of New York, The	Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch
US5045538A (en) *	1990-06-28	1991-09-03	The Research Foundation Of State University Of New York	Inhibition of wasting and protein degradation of mammalian muscle by tetracyclines
US5321008A (en) *	1991-01-10	1994-06-14	Amylin Pharmaceuticals, Inc.	Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
EP0599397B1 (en) *	1992-11-17	1996-08-28	The Research Foundation Of State University Of New York	Tetracyclines including non-antimicrobial chemically-modified tetracyclines inhibit excessive collagen crosslinking during diabetes
WO1995013805A1 (en) *	1993-11-17	1995-05-26	Duke University Medical Center	Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
WO1996031242A1 (en) *	1995-04-07	1996-10-10	Albert Einstein College Of Medicine Of Yeshiva University	RECOMBINANT β-CELL AND USES THEREOF

1997
- 1997-06-23 US US08/880,945 patent/US5929055A/en not_active Expired - Lifetime
1998
- 1998-04-08 KR KR1019997012200A patent/KR20010020497A/ko not_active Application Discontinuation
- 1998-04-08 MX MXPA99011821A patent/MXPA99011821A/es unknown
- 1998-04-08 WO PCT/US1998/006927 patent/WO1998058658A1/en not_active Application Discontinuation
- 1998-04-08 IL IL13364398A patent/IL133643A0/xx unknown
- 1998-04-08 EP EP98914580A patent/EP1017414A4/en not_active Withdrawn
- 1998-04-08 AU AU68899/98A patent/AU744846B2/en not_active Ceased
- 1998-04-08 JP JP50438999A patent/JP2002511864A/ja not_active Ceased
- 1998-04-08 CA CA002294169A patent/CA2294169A1/en not_active Abandoned

Publication	Publication Date	Title
JP2000507042A5 (ja)	2005-09-08
JP2000509912A5 (ja)	2005-09-08
JP2000509942A5 (ja)	2007-09-06
JP2000509637A5 (ja)	2005-10-06
JP2000510751A5 (ja)	2005-10-06
JP2000509635A5 (ja)	2005-10-06
JP2000507433A5 (ja)	2005-03-10
JP2000507369A5 (ja)	2005-09-08
JP2000509587A5 (ja)	2005-09-08
JP2000508866A5 (ja)	2005-09-08
JP2000510793A5 (ja)	2005-07-14
JP2000508022A5 (ja)	2005-01-13
JP2002511864A5 (ja)	2005-12-02
JP2000508841A5 (ja)	2005-10-06
JP2000508680A5 (ja)	2005-11-24
JP2000509804A5 (ja)	2005-10-06
JP2000509853A5 (ja)	2006-03-02
JP2000509755A5 (ja)	2005-10-06
JP2000510969A5 (ja)	2005-09-08
JP2000508836A5 (ja)	2005-09-08
JP2000510247A5 (ja)	2005-09-08
JP2000509818A5 (ja)	2004-10-28
JP2000509520A5 (ja)	2005-09-08
JP2000507434A5 (ja)	2005-07-14
JP2000508880A5 (ja)	2005-08-11